Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3510LO3W
Performance in the last:
Follow this Portfolio
1D 0.7 %
1W 4.4 %
2W 0.5 %
1M -0.3 %
3M -4.7 %
6M -6.6 %
9M -6.1 %
1Y -6.4 %
Alpha
-23.5%
Beta
0.75
sharpe-R
-0.12
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:40
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -22.26%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 10.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
PODD Insulet Corporation Equity Buy 11.35% 15.22%
ESPR Esperion Therapeutics, Inc. Equity Buy 8.74% -2.73%
NVCR NovoCure Limited Equity Buy 8.71% -0.17%
MYGN Myriad Genetics, Inc. Equity Buy 9.1% 6.04%
The percentage of cash held in the portfolio is: 62.11%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 11.32% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 8.68% -3.83%
NVCR NovoCure Limited Buy 8.72% -0.5%
MYGN Myriad Genetics, Inc. Buy 8.92% 3.45%
The percentage of cash held in the portfolio is: 62.37%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 7.43%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 10.3% 1.14%
PODD Insulet Corporation Buy 11.52% 12.73%
TVTX Travere Therapeutics, Inc. Buy 12.23% 31.25%
ESPR Esperion Therapeutics, Inc. Buy 8.91% -4.37%
NVCR NovoCure Limited Buy 8.69% -3.99%
MYGN Myriad Genetics, Inc. Buy 8.71% -2.15%
The percentage of cash held in the portfolio is: 39.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 8.41%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 10.59% 3.11%
AADI Aadi Bioscience, Inc. Buy 10.79% 5.14%
PODD Insulet Corporation Buy 11.47% 11.4%
TVTX Travere Therapeutics, Inc. Buy 11.97% 27.5%
ESPR Esperion Therapeutics, Inc. Buy 8.93% -4.92%
NVCR NovoCure Limited Buy 8.7% -4.54%
MYGN Myriad Genetics, Inc. Buy 8.74% -2.56%
The percentage of cash held in the portfolio is: 28.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -3.75%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.09% -1.69%
AGEN Agenus Inc. Buy 10.25% -0.18%
AADI Aadi Bioscience, Inc. Buy 10.43% 1.71%
PODD Insulet Corporation Buy 11.4% 10.8%
TVTX Travere Therapeutics, Inc. Buy 12.55% 33.75%
ESPR Esperion Therapeutics, Inc. Buy 8.87% -5.46%
NVCR NovoCure Limited Buy 8.53% -6.37%
MYGN Myriad Genetics, Inc. Buy 8.99% 0.26%
The percentage of cash held in the portfolio is: 18.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.29% 0.21%
CARA Cara Therapeutics, Inc. Buy 9.28% -9.62%
AGEN Agenus Inc. Buy 9.63% -6.22%
AADI Aadi Bioscience, Inc. Buy 10.61% 3.43%
PODD Insulet Corporation Buy 11.03% 7.2%
TVTX Travere Therapeutics, Inc. Buy 12.57% 33.96%
ESPR Esperion Therapeutics, Inc. Buy 8.71% -7.1%
NVCR NovoCure Limited Buy 8.38% -7.98%
MYGN Myriad Genetics, Inc. Buy 9.02% 0.63%
The percentage of cash held in the portfolio is: 10.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.73% 3%
CARA Cara Therapeutics, Inc. Buy 9.78% -6.12%
AGEN Agenus Inc. Buy 9.43% -9.51%
AADI Aadi Bioscience, Inc. Buy 10.89% 4.57%
PODD Insulet Corporation Buy 10.97% 5.05%
TVTX Travere Therapeutics, Inc. Buy 10.89% 14.37%
ESPR Esperion Therapeutics, Inc. Buy 8.59% -9.84%
ALDX Aldeyra Therapeutics, Inc. Buy 8.97% -3.01%
NVCR NovoCure Limited Buy 8.65% -6.48%
MYGN Myriad Genetics, Inc. Buy 9.1% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.24% -1.42%
ORGO Organogenesis Holdings Inc. Buy 9.69% -6.71%
CARA Cara Therapeutics, Inc. Buy 9.72% -6.41%
AGEN Agenus Inc. Buy 9.5% -8.59%
AADI Aadi Bioscience, Inc. Buy 10.67% 2.86%
PODD Insulet Corporation Buy 11.01% 5.72%
TVTX Travere Therapeutics, Inc. Buy 9.82% 3.44%
ESPR Esperion Therapeutics, Inc. Buy 8.92% -6.01%
ALDX Aldeyra Therapeutics, Inc. Buy 9.22% 0%
NVCR NovoCure Limited Buy 9.22% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 9.84% -5.21%
ORGO Organogenesis Holdings Inc. Buy 9.91% -4.59%
CARA Cara Therapeutics, Inc. Buy 9.75% -6.12%
AGEN Agenus Inc. Buy 9.21% -11.33%
AADI Aadi Bioscience, Inc. Buy 10.67% 2.86%
PODD Insulet Corporation Buy 10.82% 3.96%
TVTX Travere Therapeutics, Inc. Buy 9.93% 4.69%
ESPR Esperion Therapeutics, Inc. Buy 9.44% -0.55%
ALDX Aldeyra Therapeutics, Inc. Buy 9.21% 0%
The percentage of cash held in the portfolio is: 11.21%
New Assets Added
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.08% -2.65%
ORGO Organogenesis Holdings Inc. Buy 9.99% -3.53%
CARA Cara Therapeutics, Inc. Buy 10% -3.5%
AGEN Agenus Inc. Buy 9.38% -9.51%
CERS Cerus Corporation Buy 9.52% -7.98%
AADI Aadi Bioscience, Inc. Buy 10.29% -0.57%
PODD Insulet Corporation Buy 10.5% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.3% -10.38%
TVTX Travere Therapeutics, Inc. Buy 9.47% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TVTX
  • ESPR
Assets Removed
Asset Action Perf %
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.64% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 9.57% -4.2%
ORGO Organogenesis Holdings Inc. Buy 10.34% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.37% 3.79%
AGEN Agenus Inc. Buy 9.33% -6.58%
CERS Cerus Corporation Buy 9.39% -5.88%
AADI Aadi Bioscience, Inc. Buy 9.58% -4%
NEOG Neogen Corporation Buy 9.77% -2.15%
PODD Insulet Corporation Buy 10.01% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.01% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.55% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 9.72% -0.64%
ORGO Organogenesis Holdings Inc. Buy 10.16% 3.89%
CARA Cara Therapeutics, Inc. Buy 10.24% 4.66%
AGEN Agenus Inc. Buy 10.07% 2.93%
CERS Cerus Corporation Buy 9.53% -2.52%
AADI Aadi Bioscience, Inc. Buy 9.38% -4%
NEOG Neogen Corporation Buy 9.78% 0%
The percentage of cash held in the portfolio is: 21.57%
New Assets Added
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.51% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 9.6% -0.05%
ORGO Organogenesis Holdings Inc. Buy 10.28% 7.07%
CARA Cara Therapeutics, Inc. Buy 10.36% 7.87%
AGEN Agenus Inc. Buy 10.3% 7.31%
CERS Cerus Corporation Buy 9.59% 0%
AADI Aadi Bioscience, Inc. Buy 9.59% 0%
The percentage of cash held in the portfolio is: 30.77%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.4% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 9.72% -1.79%
ORGO Organogenesis Holdings Inc. Buy 9.61% -2.83%
CARA Cara Therapeutics, Inc. Buy 9.9% 0%
AGEN Agenus Inc. Buy 9.9% 0%
The percentage of cash held in the portfolio is: 51.48%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.8% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 9.8% 0%
ORGO Organogenesis Holdings Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 70.6%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All -1.57%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 9.14% -7.66%
The percentage of cash held in the portfolio is: 90.86%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
RCM Sell All 7.14%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.53% 7.06%
CYH Community Health Systems, Inc. Buy 9.33% -5.3%
RMD ResMed Inc. Buy 9.11% 3.67%
The percentage of cash held in the portfolio is: 72.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All -5.42%
FATE Sell All 7.71%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 12.18% -1.06%
FATE Fate Therapeutics, Inc. Buy 14.65% 19.02%
RCM R1 RCM Inc. Buy 9.35% 7.83%
CYH Community Health Systems, Inc. Buy 9.4% -1.96%
RMD ResMed Inc. Buy 9.2% 7.5%
The percentage of cash held in the portfolio is: 45.23%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 12.19% 2.25%
FATE Fate Therapeutics, Inc. Buy 16.33% 37.02%
RCM R1 RCM Inc. Buy 8.3% -1.15%
CYH Community Health Systems, Inc. Buy 9.6% 3.34%
HQY HealthEquity, Inc. Buy 9.01% -3.09%
HCSG Healthcare Services Group, Inc. Buy 8.44% -1.12%
RMD ResMed Inc. Buy 8.49% 2.5%
The percentage of cash held in the portfolio is: 27.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All 1.14%
OPK Sell All 7.58%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.26% -1.7%
OPK OPKO Health, Inc. Buy 9.1% 8.33%
BKD Brookdale Senior Living Inc. Buy 12.45% 3.44%
FATE Fate Therapeutics, Inc. Buy 15.88% 31.88%
RCM R1 RCM Inc. Buy 8.39% -1%
CYH Community Health Systems, Inc. Buy 9.51% 1.38%
HQY HealthEquity, Inc. Buy 9.09% -3.16%
HCSG Healthcare Services Group, Inc. Buy 8.58% -0.43%
RMD ResMed Inc. Buy 8.37% 0%
The percentage of cash held in the portfolio is: 10.37%
New Assets Added
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.86% 8.52%
OPK OPKO Health, Inc. Buy 8.84% 8.33%
BKD Brookdale Senior Living Inc. Buy 12.2% 4.37%
FATE Fate Therapeutics, Inc. Buy 16.26% 39.07%
RCM R1 RCM Inc. Buy 8.02% -2.61%
CLDX Celldex Therapeutics, Inc. Buy 8.6% -4.26%
SMTI Sanara MedTech Inc. Buy 8.62% -5.45%
CYH Community Health Systems, Inc. Buy 9.27% 1.77%
HQY HealthEquity, Inc. Buy 8.96% -1.69%
HCSG Healthcare Services Group, Inc. Buy 8.37% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.8% 10.23%
OPK OPKO Health, Inc. Buy 8.95% 12.12%
BKD Brookdale Senior Living Inc. Buy 12.09% 5.69%
FATE Fate Therapeutics, Inc. Buy 15.99% 39.85%
RCM R1 RCM Inc. Buy 8.04% -0.19%
PTGX Protagonist Therapeutics, Inc. Buy 8.46% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 8.93% 1.6%
SMTI Sanara MedTech Inc. Buy 8.91% 0%
CYH Community Health Systems, Inc. Buy 8.91% 0%
HQY HealthEquity, Inc. Buy 8.91% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • CYH
  • HQY
Assets Removed
Asset Action Perf %
ATRC Sell All -12.65%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.93% 11.93%
OPK OPKO Health, Inc. Buy 8.58% 7.58%
BKD Brookdale Senior Living Inc. Buy 11.82% 3.44%
FATE Fate Therapeutics, Inc. Buy 15.87% 38.82%
ATRC AtriCure, Inc. Buy 9.75% -7%
RCM R1 RCM Inc. Buy 7.98% -0.84%
PTGX Protagonist Therapeutics, Inc. Buy 8.72% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 8.78% 0%
The percentage of cash held in the portfolio is: 19.57%
New Assets Added
  • CLDX
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.58% 6.96%
OPK OPKO Health, Inc. Buy 8.63% 7.58%
BKD Brookdale Senior Living Inc. Buy 11.93% 3.7%
FATE Fate Therapeutics, Inc. Buy 15.31% 33.16%
ATRC AtriCure, Inc. Buy 10% -5.18%
RCM R1 RCM Inc. Buy 8.17% 0.92%
PTGX Protagonist Therapeutics, Inc. Buy 8.84% 0%
The percentage of cash held in the portfolio is: 28.53%
New Assets Added
  • PTGX
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.01% 10.8%
OPK OPKO Health, Inc. Buy 9% 10.61%
BKD Brookdale Senior Living Inc. Buy 11.98% 2.78%
FATE Fate Therapeutics, Inc. Buy 13.67% 17.22%
ATRC AtriCure, Inc. Buy 10.07% -5.85%
RCM R1 RCM Inc. Buy 8.39% 2.15%
The percentage of cash held in the portfolio is: 37.89%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Sell All 13.4%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 10.24% 9.54%
PDSB PDS Biotechnology Corporation Buy 9.05% 9.94%
OPK OPKO Health, Inc. Buy 9.29% 12.88%
BKD Brookdale Senior Living Inc. Buy 11.94% 1.19%
FATE Fate Therapeutics, Inc. Buy 12.95% 9.77%
ATRC AtriCure, Inc. Buy 10.33% -4.47%
RCM R1 RCM Inc. Buy 8.47% 2%
The percentage of cash held in the portfolio is: 27.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 10.18% 9.54%
PDSB PDS Biotechnology Corporation Buy 8.98% 9.66%
ALT Altimmune, Inc. Buy 7.17% -12.43%
OPK OPKO Health, Inc. Buy 9.43% 15.15%
BKD Brookdale Senior Living Inc. Buy 11.92% 1.59%
FATE Fate Therapeutics, Inc. Buy 13% 10.8%
ATRC AtriCure, Inc. Buy 10.49% -2.49%
RCM R1 RCM Inc. Buy 8.14% -1.46%
The percentage of cash held in the portfolio is: 20.7%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All 17.81%
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.12% 23.12%
VRDN Viridian Therapeutics, Inc. Buy 10.43% 15.37%
PDSB PDS Biotechnology Corporation Buy 9.07% 13.92%
ALT Altimmune, Inc. Buy 7.97% 0.13%
OPK OPKO Health, Inc. Buy 8.56% 7.58%
WST West Pharmaceutical Services, Inc. Buy 7.73% -1.88%
BKD Brookdale Senior Living Inc. Buy 11.66% 2.25%
FATE Fate Therapeutics, Inc. Buy 13.07% 14.65%
ATRC AtriCure, Inc. Buy 10.36% -0.91%
RCM R1 RCM Inc. Buy 8.03% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.03% 25%
VRDN Viridian Therapeutics, Inc. Buy 10.67% 20.89%
PDSB PDS Biotechnology Corporation Buy 9.15% 17.76%
BHVN Biohaven Ltd. Buy 8.15% 4.86%
ALT Altimmune, Inc. Buy 8.42% 8.29%
OPK OPKO Health, Inc. Buy 8.48% 9.09%
WST West Pharmaceutical Services, Inc. Buy 7.6% -1.26%
BKD Brookdale Senior Living Inc. Buy 11.24% 0.93%
FATE Fate Therapeutics, Inc. Buy 13.03% 16.97%
ATRC AtriCure, Inc. Buy 10.21% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ATRC
Assets Removed
Asset Action Perf %
RARE Sell All 13.6%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
RARE Ultragenyx Pharmaceutical Inc. Buy 10.47% 11.57%
CYH Community Health Systems, Inc. Buy 11.15% 21.88%
VRDN Viridian Therapeutics, Inc. Buy 10.17% 11.2%
PDSB PDS Biotechnology Corporation Buy 9.67% 20.03%
BHVN Biohaven Ltd. Buy 8.56% 6.27%
ALT Altimmune, Inc. Buy 8.51% 5.61%
OPK OPKO Health, Inc. Buy 8.73% 8.33%
WST West Pharmaceutical Services, Inc. Buy 7.66% -3.96%
BKD Brookdale Senior Living Inc. Buy 11.54% 0%
FATE Fate Therapeutics, Inc. Buy 11.54% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BKD
  • FATE
Assets Removed
Asset Action Perf %
ACAD Sell All 13.54%
EGRX Sell All 33.26%
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.77% 11.15%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.04% 34.6%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.67% 10.14%
CYH Community Health Systems, Inc. Buy 10.95% 15.94%
VRDN Viridian Therapeutics, Inc. Buy 9.26% -1.97%
PDSB PDS Biotechnology Corporation Buy 9.17% 10.23%
BHVN Biohaven Ltd. Buy 8.73% 4.89%
ALT Altimmune, Inc. Buy 8.54% 2.67%
OPK OPKO Health, Inc. Buy 8.63% 3.79%
WST West Pharmaceutical Services, Inc. Buy 8.24% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
Assets Removed
None
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings